RxSight

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

RxSight strives to provide superior products and services to enable healthcare providers to improve patient care.

RxSight’s goal is to be a leader in retinal imaging, pioneering revolutionary products and applications that set the gold standard of care.

RxSight has been the recipient of numerous awards, including The MDDI Medical Technology Entrepreneur Award, The MIT Inclusive Innovation Prize and The Red Herring Top 100 North America Award.